× Search


 Prevennia® Executive Team
 Executive Advisory Board
John Raffanti Founder and CEO

John Raffanti, with over 35 successful years of business management, is known for his highly motivational, results oriented management style. He has a proven ability to strategically plan and execute programs as well as build teams that effectively resolve organizational needs and objectives.

John, with his extensive executive management experience, has spent his career forming massive sales and marketing teams known for producing quality, team driven, successful programs. He was responsible for operations and financials as the Director of Procurement and Marketing for Ritz Foodservice, with annual sales exceeding $80 million.

John succeeded in adapting to the food service industry’s changing markets by strategically and tactically implementing results oriented processes in a highly competitive market. John was responsible for sourcing and implementing global purchasing in China for Disposable Categories, rolling out new product lines, managing the procurement staff to obtain proper product mix and control of inventory to generate excellent service levels in excess of 99.5%, while maintaining inventory turns, and selecting & controlling products and margins to generate proper ROI.

As the Executive Vice President of the Bakery Division of U.S. Foodservice, John was responsible for the Foodservice Bakery Division, Bread Division and Nevada Baking Company with annual sales exceeding $50 million. John’s enthusiasm and quest to make Prevennia a household name, protect lives and allow people to live fuller, richer and longer lives is the drive behind developing the Prevennia organization.

Michael Quattro President

With over thirty-five years in the Pharmaceutical and Biotech industry, Mike is a dynamic sales and marketing leader with a proven record of commercial success in specialty and mass markets. Mike has served as Scientific Consultant for EQ Biosciences since 2010.

He was the President and CEO of Quattro and Associates, LLC. And was brought on by organizations to design, develop and implement a wide variety of commercial projects for biotechnology, pharmaceutical and service agencies. His clients also included capital investment groups, venture capital groups and non-profit foundations. He was often retained to lead strategic marketing assessments for new products, in-line products and portfolio development, to conduct competitive intelligence activities at medical professional society meetings and generated comprehensive reports in diabetes, oncology, neurology and cardiology.

Mike served previously as Senior Vice President of Global Marketing for Nektar Therapeutics; Vice President of Marketing for Amylin Pharmaceuticals, Inc., Vice President of Marketing at Berlex Oncology, a division of Schering AG, and many other positions of increasing responsibility in the pharmaceutical industry.

Mike was educated at Rhode Island College, obtaining his Bachelor’s and Master’s degrees in Biological Sciences. His business education was at the Johnson School of Business, Cornell University.

Dr. Luis Joy MD, Vice President of Business Development Hispanic Market

Dr. Joy graduated in 1980 from “Universidad Autónoma de Santo Domingo” with a degree of Doctor in Medicine. He completed his specialty in Family Medicine at the University of Puerto Rico in 1984. And accepted into the “American Board of Family Practice”, “American Board of Geriatrics” and “American Board of Chelation Therapy”. In 2004 he also received his diploma “in Clinical Homeopathy” from the “Center for Education and Development of Homeopathy” ( C.E.D.H,) USA”.

Dr. Joy has been President of “ Association of Homeopathy and Complementary Therapies of Puerto Rico” and also President of the Puerto Rico Chapter of the “international and American Association of Clinical Nutrition”.

He has lectured in numerous conferences and taught about multiple themes and courses related to: Minor Surgery , Pain, Temporal Mandibular Disorders (TMD or TMJ), Acupuncture, Soft Lasers, Homeopathy, Clinical Nutrition, and Anti- Aging Medicine ( being the pioneer of Anti-Aging Medicine in Puerto Rico since 1996) for Doctors & Dentists in Puerto Rico.

Dr. Joy has been practicing medicine for over 28 years after finishing his post- graduate studies. He was the Medical Director of “ Hospital General Castañar” from 1984-1985. He has been in private practice since 1985. He has taught Alternative & Complementary Therapies to resident Doctors of Family Medicine of Puerto Rico and Naturopathic Medicine of the USA. And he hosted two radio shows related , one lasting over 6 years, that covered all topics related to health. Dr. Joy is an untiring student in search of the truth and most effective therapies with the minimum possible risks for his patients. This passion for providing the best possible care to his patients, led him 18 years ago to start “ Pro Health Joy Institute “ in Corozal , Puerto Rico.

Dr. Joy is presently affiliated to the “ American College for Advancement of Medicine” , “ American Association of pain Management, Sclerotherapy & Prolotherapy” (since 1993) and “American Association of Anti-Aging Medicine (since 1996). Since 1991 he has been a member of the “ American Academy of Biological Dentistry” , “American Academy of Biological Dentistry” , “ International Academy of Oral Medicine & Toxicology” and to the “ Asociación de Acupuntura Médica de Puerto Rico”.

Dr. David A. Westbrock, MD, FACP, FACE Advisory Board Medical Chairman

Dr. David Westbrock has been in private practice for over 30 years in Dayton, Ohio. He is certie- d by the American Board of Internal Medicine in Internal Medicine and Endocrinology/Metabolism. He received his undergraduate degree from the University of Dayton and his medical degree from the Ohio State University.

Dr. Westbrock is an associate clinical professor of medicine at Wright State University and a Fellow of both the American College of Physicians (FACP) and the American College of Endocrinology (FACE). He was a member of the board of trustees of the American Association of Clinical Endocrinology (AACE) where he has served as parliamentarian. In 1998, he founded the Ohio Chapter of AACE. He was also a member of the Advisory Council of the University of Dayton College of Arts and Sciences. Dr. Westbrock is a member of the Montgomery County Medical Society. He was a member of the board of directors from 1986-1997, and served as president from 1996-1997. Dr. Westbrock was a member of the Board of Trustees of the Western Ohio Foundation for Medical Care from 1985-1993 and served as Secretary-Treasurer. He served on the Physicians Advisory Committee for the Diabetes Association of the Dayton Area and on the Board of Trustees for the American Diabetes Association, Dayton Area Af-filiate from 1978-1984.

In 1979, he established the metabolic unit at the Miami Valley Hospital, and started the first inpatient diabetes insulin pump program in the Greater Dayton area. As the Vice President for Global Business development for InPhase International (IPI). He has been active in improving the delivery and ef-ficiency by improving technological and innovative solutions in health care through consumer directed information and delivery systems. He is currently developing a comprehensive health reform program, Consumer First Health Network, serving as its President. Active in helping to form health care policy and spark research projects, Dr. Westbrock has served as an Adjunct Policy Advisor for Health Care for the Buckeye Institute for Public Policy Solutions; a member of the Board of Governors College of Medicine Alumni Society for the Ohio State University; and he has written numerous articles for health care periodicals. Dr. Westbrock is a member of Reach Out, Montgomery County, Inc. As a participating physician, he regularly sees patients who do not have health insurance. Dr. Westbrock has worked as a volunteer physician at a free clinic in Somerset, Kentucky. Additionally, he is a former youth soccer, basketball and baseball coach.

Dr. Westbrock is one of the Dayton-area’s premier obesity experts. He created New Profile Weight Management Center in 1998. In it, he aims to create a permanent solution for patients’ health as it relates to weight management as well as a model for preventative health care in other chronic disease states. He serves on the AACE committee to establish national guidelines for the medical management of obesity He has a regular video internet page, Ask Dr Dave.

Dr Westbrock left his full time private practice in June, 2010, and currently does house calls, serving patients who are unable to see a private family due to chronic debilitating illness, serious respiratory disease, or serious debilitating dementia. In November, 2009, he organized the Montgomery County Health Care Summit, bringing together representatives from Montgomery County and Ohio State government, the Dayton Chamber of Commerce, The Montgomery County Medical Society, and the Greater Dayton Hospital Association to discuss and develop strategies to better serve the needs of the local community through local action in contrast to federal programs. He is a founder to Take It Back America, an organization focusing on the challenges to small business during the current economic recession.

A Dayton-area resident for the vast majority of his life, Dr. Westbrock has been married for to Judy for 40 years. They have three children, and three grandchildren.

Legal Advisory Board
Victor Perry Corporate Legal

Victor Alan Perry, Esq. practices in the areas of business litigation, toxic torts, professional errors and omissions and transportation law.

He is a member of the American Bar Association, American Arbitration Association (mediator), Association of Defense Counsel, Defense Research Institute, State Bar of Nevada, Washoe County Bar Association and the Clark County Bar Association.

Mr. Perry was admitted to the Nevada Bar in 1970 and has since been admitted to practice in all the courts in the State of Nevada, Federal District Court, Ninth Circuit Court of Appeals, and the U.S. Supreme Court. He graduated from the Colorado School of Mines with an Engineering of Mines degree in 1961 and from the University of Denver with his J.D. in 1970. Upon graduation, Victor served as a Deputy Attorney General for the State of Nevada for three years.

When he left the Attorney General’s staff, Victor founded the -rm of Perry & Spann, P.C. with of-fices in Las Vegas andReno, Nevada. Perry & Spann is recognized as one of the finest insurance defense firms in Nevada.

He served as a Deputy Attorney General in the State of Nevada with the Department of Highways from 1971 to 1973, and several years as Honorary Consul for Mexico for the State of Nevada. Victor was recently approved by the United States Department of State to accept the position of Honorary Consul for the Republic of Namibia, in the State of Nevada.

About EQ Biosciences, Inc.

EQ Biosciences, Inc. is a Nevada C Corporation company formed to manufacture and market an exciting proprietary dietary supplement, Prevennia®, which credible scientific research has shown will assist the human body

in preventing the initiation of breast and prostate cancers. Another function of EQ Biosciences, Inc. is to provide funding to our scientists to aid their continuing research in broadening the scope for verified applications of Prevennia®.

Our scientists have been engaged in cancer research since the late 1960s. Their work has been reviewed, published, critiqued, and accepted by their peers in the scientific community and has led to the granting of patents on the testing procedures, and a patent pending on the uses of Prevennia® in a wide variety of areas.

Prevennia®, when taken on a regular basis, will assist the body in preventing the formation of estrogen adducts which can cause damage to DNA, thus starting a cell on its way to forming or initiating breast or prostate cancer.

The results of these tests have convinced the organizers of EQ Biosciences, Inc. that now is the time to make Prevennia® available to the public. Not only will the manufacture and sale of Prevennia® serve a public need, it is also an exciting opportunity to create a market for a beneficial dietary supplement.

Our scientists have almost a combined 100 years of research in cancer initiation and prevention. They are recognized nationally and internationally. They have been the recipients of continuous funding for over 40 years from such sources as the National Cancer Institute and the U.S. Army Breast Cancer Institute.

At formation EQ Biosciences, Inc. was composed of two initial stock holders. Previously, our scientists formed Prevention, LLC, a Nebraska limited liability company to hold the rights to their discoveries which were purchased by EQ Biosciences, Inc. for the purpose of manufacturing and marketing the patent-pending formulation in December of 2009.

John Raffanti, President and CEO of EQ Biosciences, Inc. sets the goals, defines the direction of the business, and establishes policies. John Raffanti sets the course not only for the internal team of staff and management, but also for the sales distributors. He is also responsible for developing and executing plans for expansion for international markets and for acquisition and merger strategies, which are extremely important for the Company’s long-term growth potential. John oversees all operations through a management team comprised of typical corporate “C Tree” who heads the various departments.

About Prevennia®

EQ Biosciences, Inc., a Las Vegas, Nevada company, was formed in association with the research scientists to assist women and men in achieving and maintaining healthy, normal levels of estrogen metabolites through the use of Prevennia®, a dietary supplement. Taken twice daily, Prevennia® reacts with the body’s natural processes to protect each cell and block the initiation of breast cell mutations. Research leading to Prevennia® has been funded in part by tens of millions of dollars from the National Cancer Institute and the U.S. Department of Defense.

Prevennia®, A Dietary Supplement

EQ Biosciences has developed a dietary supplement, supported by more than 40 years of cancer research by leading experts and tens of millions of dollars in funding, designed to block the initiation of cell mutations.

Prevennia®, Supported By Credible Research

Research has shown that when the body’s estrogen metabolism is unbalanced, the estrogen metabolites can react with DNA and thereby are prone to start the process leading to mutations in cells. Renowned scientists Dr. Ercole Cavalieri and Dr. Eleanor Rogan, who have been involved with these scientific findings and research for more than four decades, have published their findings in the following journals: International Journal of Cancer; Cancer Prevention Research; Breast Cancer: Basic and Clinical Research; Prostate; Journal of Steroid Biochemistry and Molecular Biology; Future Oncology.




" I've been taking Prevennia for only a few months and have experienced increased mental and physical energy and, as a bonus, a substantial decrease in arthritis pain in my hands, knees and feet.

Sandy J. | Burlingame, California


Terms Of UsePrivacy StatementCopyright 2018 by EQ Biosciences, Inc. - Prevennia
Back To Top